Literature DB >> 8075884

Metabolic disposition of leukotriene B4 (LTB4) and oxidation-resistant analogues of LTB4 in conscious rabbits.

S Marleau1, N Dallaire, P E Poubelle, P Borgeat.   

Abstract

1. The kinetics of leukotriene B4 (LTB4), after single i.v. injections of doses of 0.1 to 1 micrograms kg-1, were investigated in conscious rabbits and compared with those of the omega- and beta-oxidation resistant bioactive analogues, 20, 20, 20-trifluoro-LTB4 (20-F3-LTB4) and 3-thio-LTB4, respectively. 2. Immunoreactive LTB4 (IR-LTB4) elimination was first-order, as shown by a constant systemic clearance (ClLTB4) and a proportional increase in the area under the curve (AUC) of the plasma concentration versus time curve over the dose-range studied. Our results showed a good correlation between observed steady-state plasma concentrations (Css) of IR-LTB4 after continuous infusion of LTB4 and those predicted by using the mean estimated ClLTB4 of 93 +/- 4 ml min-1 kg-1, further confirming the linearity of IR-LTB4 elimination. 3. The half-life (t1/2) or IR-LTB4 increased from 0.47 +/- 0.02 to 0.63 +/- 0.04 min as a consequence of a change in the apparent volume of distribution (Vd) from 72 +/- 5 to 109 +/- 13 ml kg-1, for the 0.1 and 1 micrograms kg-1 doses injected, respectively. 4. Single i.v. injections of [3H]-LTB4 (4.7 ng kg-1) were administered, and the decay of plasma [3H]-LTB4 following h.p.l.c. purification was used to estimate the kinetic parameters. The kinetic parameters of [3H]-LTB4 were characterized by a mean systemic clearance (Cl) of 96 +/- 11 ml min-1 kg-1, a t1/2 of 0.53 +/- 0.03 min, and an apparent Vd of 85 +/- 9 ml kg-1, similar to the parameters obtained after LTB4 boluses. 5. The disposition of LTB4 analogues, whether resistant to Omega- or to Beta-oxidation in vitro, did not differ significantly from the disposition of the LTB4 molecule. The half-lives of 20-F3-LTB4 and 3-thio-LTB4 in the circulation were 0.52 +/- 0.07 min and 0.70 +/- 0.11 min, respectively.6. In summary, our results showed that LTB4, as well as Omega-oxidation- and Beta-oxidation-resistant analogues were cleared very rapidly from the rabbit circulation and indicate that in situ, metabolism in blood is not a rate-limiting factor for the elimination of LTB4.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8075884      PMCID: PMC1910361          DOI: 10.1111/j.1476-5381.1994.tb13125.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Leukotriene B4 and prostaglandin E2 mediate the inflammatory response of rabbit skin to intradermal arachidonic acid.

Authors:  D M Aked; S J Foster
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

2.  Metabolism of leukotriene B4 in isolated rat hepatocytes. Identification of a novel 18-carboxy-19,20-dinor leukotriene B4 metabolite.

Authors:  T W Harper; M J Garrity; R C Murphy
Journal:  J Biol Chem       Date:  1986-04-25       Impact factor: 5.157

3.  Leukotriene B4 and 20-OH-LTB4 in purulent peritoneal exudates demonstrated by GC-MS.

Authors:  Y Kikawa; Y Shigematsu; M Sudo
Journal:  Prostaglandins Leukot Med       Date:  1986-07

4.  Biochemical characterization of hepatic microsomal leukotriene B4 hydroxylases.

Authors:  M C Romano; R D Eckardt; P E Bender; T B Leonard; K M Straub; J F Newton
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

5.  Enhancement of plasma levels of biologically active leukotriene B compounds during anaphylaxis in guinea pigs pretreated by indomethacin or by a fish oil-enriched diet.

Authors:  T H Lee; E Israel; J M Drazen; A G Leitch; J Ravalese; E J Corey; D R Robinson; R A Lewis; K F Austen
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

6.  Leukotriene B4 production by stimulated whole blood: comparative studies with isolated polymorphonuclear cells.

Authors:  P Gresele; J Arnout; M C Coene; H Deckmyn; J Vermylen
Journal:  Biochem Biophys Res Commun       Date:  1986-05-29       Impact factor: 3.575

7.  Leukotriene B4 omega-hydroxylase in human polymorphonuclear leukocytes. Partial purification and identification as a cytochrome P-450.

Authors:  S Shak; I M Goldstein
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

8.  Studies on leukotriene B4 omega-oxidation in human leukocytes.

Authors:  M Nadeau; B Fruteau de Laclos; S Picard; P Braquet; E J Corey; P Borgeat
Journal:  Can J Biochem Cell Biol       Date:  1984-12

9.  Leukotriene B4-like material in scale of psoriatic skin lesions.

Authors:  S D Brain; R D Camp; F M Cunningham; P M Dowd; M W Greaves; A K Black
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

10.  Disappearance and metabolism of leukotriene B4 during carrageenan-induced pleurisy.

Authors:  B M Taylor; F F Sun
Journal:  Biochem Pharmacol       Date:  1985-10-01       Impact factor: 5.858

View more
  3 in total

Review 1.  The role of the LTB4-BLT1 axis in chemotactic gradient sensing and directed leukocyte migration.

Authors:  Bhagawat C Subramanian; Ritankar Majumdar; Carole A Parent
Journal:  Semin Immunol       Date:  2017-10       Impact factor: 11.130

2.  Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension.

Authors:  Wen Tian; Xinguo Jiang; Rasa Tamosiuniene; Yon K Sung; Jin Qian; Gundeep Dhillon; Lajos Gera; Laszlo Farkas; Marlene Rabinovitch; Roham T Zamanian; Mohammed Inayathullah; Marina Fridlib; Jayakumar Rajadas; Marc Peters-Golden; Norbert F Voelkel; Mark R Nicolls
Journal:  Sci Transl Med       Date:  2013-08-28       Impact factor: 17.956

3.  Trauma and hemorrhagic shock activate molecular association of 5-lipoxygenase and 5-lipoxygenase-Activating protein in lung tissue.

Authors:  Geoffrey R Nunns; John R Stringham; Fabia Gamboni; Ernest E Moore; Miguel Fragoso; Gregory R Stettler; Christopher C Silliman; Anirban Banerjee
Journal:  J Surg Res       Date:  2018-05-05       Impact factor: 2.192

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.